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Background:  Marantic endocarditis (ME) is the formation of sterile platelet and fibrin thrombi on cardiac valves and is a rare complication 
of advanced malignancy.
case:  A 68 year-old man presented to the hospital with abulia and was admitted for possible stroke. His medical history included a 
diagnosis one month ago of metastatic pancreatic adenocarcinoma. Physical exam was significant for a normal cardiovascular exam and 
right upper quadrantanopia. CT and MR brain imaging showed bilateral cerebellar and left occipital infarcts with corresponding abrupt 
occlusion of the left P2 segment of the posterior cerebellar artery, consistent with thromboembolism. Atrial fibrillation was absent on 
electrocardiogram and cardiac monitoring.
decision Making:  We had a high clinical suspicion for cardioembolism as the etiology of this patient’s bi-hemispheric ischemic infarcts. 
We performed transesophageal echocardiography, revealing normal left ventricular ejection fraction, absence of thrombus in the left 
atrium, and a small vegetation at the tip of the aortic valve (figure). A small perforation of the left coronary cusp was seen. Multiple sets of 
peripheral blood did not culture bacteria. We diagnosed ME and started subcutaneous enoxaparin.
conclusion:  This case demonstrates that ME should be considered in patients with embolic stroke in the absence of positive blood 
cultures, particularly in the setting of neoplastic disease. Management involves anticoagulation for prevention of recurrent embolism.
 
